-
EP1379268
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP1379268
| EP1379268 - CHONDROGENIC POTENTIAL OF HUMAN BONE MARROW-DERIVED CD105?+ CELLS BY BMP [Right-click to bookmark this link] | Status | The application has been withdrawn Status updated on 14.08.2009 Database last updated on 26.06.2024 | Most recent event Tooltip | 14.08.2009 | Withdrawal of application | published on 16.09.2009 [2009/38] | Applicant(s) | For all designated states Wyeth Five Giralda Farms Madison, NJ 07940 / US | [N/P] |
| Former [2004/33] | For all designated states Wyeth Five Giralda Farms Madison, New Jersey 07940 / US | ||
| Former [2004/03] | For all designated states Genetics Institute, LLC 87 Cambridge Park Drive Cambridge, MA 02140 / US | Inventor(s) | 01 /
MAJUMDAR, Manas, Kumar 14 Ruthven Avenue Burlington, MA 01803 / US | 02 /
MORRIS, Elisabeth, Ann 15 Apple Street Sherborn, MA 01770 / US | [2004/03] | Representative(s) | Denholm, Anna Marie, et al Wyeth Pharmaceuticals Huntercombe Lane South Taplow Maidenhead Berkshire SL6 0PH / GB | [2009/26] |
| Former [2007/08] | Denholm, Anna Marie, et al Wyeth Pharmaceuticals Patents & Trade Marks Department Huntercombe Lane South Taplow, Maidenhead Berkshire SL6 0PH / GB | ||
| Former [2004/03] | Ingham, Stephen H. Wyeth Pharmaceuticals, Patents & Trade Marks Dept., Huntercombe Lane South, Taplow Maidenhead, Berks SL6 0PH / GB | Application number, filing date | 02721048.3 | 19.02.2002 | [2004/03] | WO2002US04880 | Priority number, date | US20010271186P | 23.02.2001 Original published format: US 271186 P | US20010333975P | 29.11.2001 Original published format: US 333975 P | [2004/03] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO02067978 | Date: | 06.09.2002 | Language: | EN | [2002/36] | Type: | A1 Application with search report | No.: | EP1379268 | Date: | 14.01.2004 | Language: | EN | The application published by WIPO in one of the EPO official languages on 06.09.2002 takes the place of the publication of the European patent application. | [2004/03] | Search report(s) | International search report - published on: | EP | 06.09.2002 | Classification | IPC: | A61K38/18 | [2004/03] | CPC: |
A61K38/1875 (EP,US);
A61P19/02 (EP);
A61P19/08 (EP)
| C-Set: |
A61K38/1875, A61K2300/00 (EP,US)
| Designated contracting states | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE, TR [2004/03] | Extension states | AL | Not yet paid | LT | Not yet paid | LV | Not yet paid | MK | Not yet paid | RO | Not yet paid | SI | Not yet paid | Title | German: | KNORPELBILDENDES POTENTIAL VON AUS HUMANEM KNOCHENMARK-ABGELEITETEN CD105+ ZELLEN DURCH BMP | [2004/03] | English: | CHONDROGENIC POTENTIAL OF HUMAN BONE MARROW-DERIVED CD105?+ CELLS BY BMP | [2004/03] | French: | UTILISATION DES PROT INES BMP POUR POTENTIALISER LA CHONDROGEN SE PAR LES CELLULES CD105?+ TIR ES DE LA MOELLE OSSEUSE HUMAINE | [2004/03] | Entry into regional phase | 10.09.2003 | National basic fee paid | 10.09.2003 | Designation fee(s) paid | 10.09.2003 | Examination fee paid | Examination procedure | 12.09.2002 | Request for preliminary examination filed International Preliminary Examining Authority: EP | 10.09.2003 | Amendment by applicant (claims and/or description) | 10.09.2003 | Examination requested [2004/03] | 26.01.2009 | Despatch of a communication from the examining division (Time limit: M04) | 10.07.2009 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time | 06.08.2009 | Application withdrawn by applicant [2009/38] | Fees paid | Renewal fee | 04.02.2004 | Renewal fee patent year 03 | 04.02.2005 | Renewal fee patent year 04 | 06.02.2006 | Renewal fee patent year 05 | 05.02.2007 | Renewal fee patent year 06 | 08.02.2008 | Renewal fee patent year 07 | Penalty fee | Additional fee for renewal fee | 28.02.2009 | 08 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [X]WO9410187 (HSC RES DEV LP [CA], et al) [X] 15,16 * claims 10-13 *; | [XY]WO9628539 (MORPHOGEN PHARMACEUTICALS INC [US], et al) [X] 1,5,9,15,28 * page 5, line 16 - line 25 * * page 7, line 21 * [Y] 17,30; | [XAY]WO9832333 (OSIRIS THERAPEUTICS INC [US], et al) [X] 1,5,9,10,13,15,28 * page 6, paragraph 2 * * claims 1,6,8-11,25,35 * * page 12, paragraph 3 * [A] 18-20,31 [Y] 17,30; | [X]WO9833515 (UNIV CASE WESTERN RESERVE [US]) [X] 13,15,28 * the whole document *; | [X]WO0044413 (GENETICS INST [US]) [X] 1,5,9,10 * page 3; claim 8 *; | [X] - PLOEMACHER R.E. ET AL., "Bone morphogenetic protein 9 is a potent synergistic factor for murine hemopoietic progenitor cell generation and colony formation in serum-free cultures.", LEUKEMIA, (199903), vol. 13, no. 3, pages 428 - 437, XP001085128 [X] 1,5,9,10,14,15,28 * abstract * DOI: http://dx.doi.org/10.1038/sj/leu/2401363 | [X] - BRUDER S. P. ET AL., "Mesenchymal stem cells in bone development, bone repair, and skeletal regeneration therapy.", JOURNAL OF CELLULAR BIOCHEMISTRY, (199411), vol. 56, no. 3, pages 283 - 294, XP002082633 [X] 15 * the whole document * DOI: http://dx.doi.org/10.1002/jcb.240560303 | [X] - PIERELLI LUCA ET AL, "CD34+/CD105+ cells are enriched in primitive circulating progenitors residing in the GO phase of the cell cycle and contain all bone marrow and cord blood CD34+/CD38low/- precursors.", BRITISH JOURNAL OF HAEMATOLOGY, (200003), vol. 108, no. 3, ISSN 0007-1048, pages 610 - 620, XP001085019 [X] 15,16 * page 617, column L * * page 619, column L * DOI: http://dx.doi.org/10.1046/j.1365-2141.2000.01869.x | [A] - ALTOMONTE M ET AL, "EXPRESSION AND STRUCTURAL FEATURES OF ENDOGLIN (CD105), A TRANSFORMING GROWTH FACTOR BETA1 AND BETA3 BINDING PROTEIN, IN HUMAN MELANOMA", BRITISH JOURNAL OF CANCER, LONDON, GB, (1996), vol. 74, no. 10, ISSN 0007-0920, pages 1586 - 1591, XP000886640 [A] 16,29 * abstract * |